Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

SIGMAPHARM LABS LLC

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 29
  • 0 comments

FDA approve AMBRISENTAN

Comment Full text

MYLAN

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 34
  • 0 comments

FDA approve AMBRISENTAN

Comment Full text

ENDO OPERATIONS

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 41
  • 0 comments

FDA approve AMBRISENTAN

Comment Full text

EDENBRIDGE PHARMS

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 35
  • 0 comments

FDA approve COLESTIPOL HYDROCHLORIDE

Comment Full text

TEVA PHARMS USA INC

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 39
  • 0 comments

FDA approve LAPATINIB DITOSYLATE

Comment Full text

GILEAD

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 36
  • 0 comments

FDA approve AMBRISENTAN

Comment Full text

Liquidia Technologies, Inc.

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 38
  • 0 comments

FDA approve TREPROSTINIL

Comment Full text

HETERO LABS LTD V

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 42
  • 0 comments

FDA approve SILODOSIN

Comment Full text

ALKEM LABS LTD

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 35
  • 0 comments

FDA approve DABIGATRAN ETEXILATE MESYLATE

Comment Full text

WATSON LABS INC

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 32
  • 0 comments

FDA approve AMBRISENTAN

Comment Full text
  • Previous
  • 372
  • 373
  • 374
  • 375
  • 376
  • Next

Search

News categories

  • Technical Exchange News(11519)
  • Event(3471)
  • SEC News(216927)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(137927)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin